期刊文献+

甲状腺功能亢进症合并肺动脉高压临床分析 被引量:9

Clinical features of pulmonary hypertension associated with hyperthyroidism
原文传递
导出
摘要 回顾性分析87例甲状腺功能亢进症(甲亢)患者的临床特点和肺动脉高压发生的相关因素,结果显示1/3甲亢患者合并肺动脉高压,高龄、左室收缩或舒张功能下降是甲亢伴发肺动脉高压的危险因素(均P〈0.05),自身免疫因素在其发病机制中的作用依据不足(P〉0.05)。 Eighty-seven patients with hyperthyroidism were enrolled in a retrospective study, and 35.6% of them also suffered from pulmonary hypertension(PH). Advanced age and systolic or diastolic dysfunction of left heart were risk factors in the mechanism of PH associated with hyperthyroidism ( all P 〈 0.05 ). However, autoimmune disorder was found as a non-related factor in the mechanism of PH( P〉0.05 ).
作者 张佳李红
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2014年第2期133-134,共2页 Chinese Journal of Endocrinology and Metabolism
关键词 甲状腺功能亢进症 肺动脉高压 Hyperthyroidism Pulmonary hypertension
  • 相关文献

参考文献13

  • 1Simonneau G,Robbins IM,Beghetti M. Updated clinical classification of pulmonary hypertension[J].Journal of the America College of Cardiology,2009,(Suppl):S43-S54.
  • 2Charalampopoulos A,Raphael C,Gin-Sing W. Diagnosing and managing pulmonary hypertension[J].PRACTITIONER,2012.21-25,2-3.
  • 3Siu CW,Zhang XH,Yung C. Hemodynamic changes in hyperthyroidism-related pulmonary hypertension:A prospective echocardiographic study[J].Journal of Clinical Endocrinology and Metabolism,2007.1736-1742.
  • 4Yazar A,Doven O,Atis S. Systolic pulmonary artery pressure and serum uric acid level in patients with hyperthyroidism[J].ARCHIVES OF MEDICAL RESEARCH,2003.35-40.
  • 5Marvisi M,Zambrelli P,Brianti M. Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy[J].European Journal of internal medicine,2006.267-271.
  • 6Hegazi MO,El Sayed A,El Ghoussein H. Pulmonary hypertension responding to hyperthyroidism treatment[J].Respirology,2008.923-925.
  • 7Hegazi MO,Ahmed S. Atypical clinical manifestations of Graves' disease:An analysis in depth[J].J Thyroid Res,2012.768019.
  • 8Danzi S,Klein I. Thyroid hormone and blood pressure regulation[J].Current Hypertension Reports,2003.513-520.
  • 9Smit JW,Eustatia-Rutten CF,Corssmit EP. Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism:a randomized,placebo-controlled study[J].Journal of Clinical Endocrinology and Metabolism,2005.6041-6047.
  • 10Biondi B,Kahaly GJ. Cardiovascular involvement in patients with different causes of hyperthyroidism[J].Nat Rev Endocrinol,2010.431-443.

同被引文献58

  • 1中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:899
  • 2Lin JZ, Sieglaff DH, Yuan C, et al. Gene specific actions of thyroid hormone receptor subtypes[J]. PLoS One, 2013, 8 (1) : e52407.
  • 3Vargas-Uricoechea H, Bonelo-Perdom A, Sierra-Tortes CH. Effects of thyroid hormones on the heart [J]. Clin Invest Arterioscl, 2014,26(6) : 296-309.
  • 4Mitchell JE, Hellkamp AS,Mark DB, et al. Thyroid function in heart failure and impact on mortality[J]. JACC Heart Fail,2013,1(1), 48- 55.
  • 5Grais IM, Sowers JR. Thyroid and the heart[J]. Am J Med, 2014,127 (8) : 691-698.
  • 6Chan PH, Hai J, Yeung CY, et al. Benefit of anticoagulation therapy in hyperthyroidism-related atrial fibrillation[J]. Clin Cardiol, 2015, 38(8):476-582.
  • 7Narayana SK, Woods DR, Boos CJ. Management ot: amiodarone-related thyroid problems[J].Ther Adv Endoerinol Metab, 2011,2(3) :115-126.
  • 8Sugiura T, Yamanaka S, Takeuchi H, et aI. Autoimmunity and pulmonary hypertension in patients with Graves disease [J].Heart Vessels, 2015, 30(5):642-646.
  • 9Bahn RS, Burch HB, Cooper DS, et al. American Thyroid Association; American Association of clinical endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists[J]. Endocr Pract,2011,17(3) :456-520.
  • 10Rodondi N, Bauer DC. Subclinical hypothyroidism and cardiovascular risk: how to end the controversy[J]. JCEM, 2013, 98(6) 2267-2269.

引证文献9

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部